AstraZeneca to deliver Covid-19 antibody therapy doses to Switzerland
AstraZeneca has signed a deal with the Switzerland FOPH to deliver over 1,200 doses of tixagevimab and cilgavimab combination for Covid-19.
Stay updated with breaking news from Finish Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca has signed a deal with the Switzerland FOPH to deliver over 1,200 doses of tixagevimab and cilgavimab combination for Covid-19.
Biotech venture financing for innovator drugs in the US reached a total of $72bn from 2017 to 2022, while only $16bn was raised in Europe.
The global Covid death toll has passed the grim milestone of 6 million, with a figure of 6,007,367 according to Johns Hopkins University.
Share this article Share this article ResearchAndMarkets.com's offering. This report features an extensive study of the current market landscape and the future potential of sterile fill/finish services for small molecule drugs. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Small molecule drugs account for nearly 90% of the contemporary therapeutics pipeline. In fact, in 2019, the FDA's Center for Drug Evaluation and Research approved 48 small molecule drugs, representing 70% of the new molecular entities (NMEs) clearing regulat...